111 related articles for article (PubMed ID: 2623252)
1. [Pulmonary toxicity of amiodarone].
Sevillano Martín C; Callol Sánchez L; Calderón Alvarez J; Moreno Muro M; Gómez de Terreros FJ
Rev Clin Esp; 1989 Nov; 185(7):362-5. PubMed ID: 2623252
[TBL] [Abstract][Full Text] [Related]
2. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary responses to amiodarone in hamsters: comparison of intratracheal and oral administrations.
Blake TL; Reasor MJ
Toxicol Appl Pharmacol; 1995 Apr; 131(2):325-31. PubMed ID: 7716773
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone pulmonary toxicity: clinical and subclinical features.
Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
[TBL] [Abstract][Full Text] [Related]
5. [Spectrometric and ultrastructural study of pneumopathy induced by amiodarone].
Breton JL; Depierre A; Garnier G
Ann Med Interne (Paris); 1985; 136(1):76-7. PubMed ID: 4003996
[No Abstract] [Full Text] [Related]
6. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
[TBL] [Abstract][Full Text] [Related]
7. [Pneumopathies caused by hypersensitivity to amiodarone and associated nephropathies. Study by alveolar lavage].
Caubarrère I; Bonan G; Venet A; Chebat J; Uzzan D; Gilbert J; Beaufils H
Ann Med Interne (Paris); 1985; 136(4):311-5. PubMed ID: 4037586
[TBL] [Abstract][Full Text] [Related]
8. [Pneumonitis and pulmonary fibrosis due to amiodarone. Report of 2 cases with optic and electronic microscopy].
Lunardi W; Lopes EA; Kehde E; Vargas FS; Pereira Júnior W; Uip DE; Cukier A; Terra Filho M; Hernández EA; Duarte MI
Arq Bras Cardiol; 1986 Jun; 46(6):415-9. PubMed ID: 3579634
[No Abstract] [Full Text] [Related]
9. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis.
Ohar JA; Jackson F; Dettenmeier PA; Bedrossian CW; Tricomi SM; Evans RG
Chest; 1992 Oct; 102(4):999-1004. PubMed ID: 1395816
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of amiodarone pulmonary toxicity.
Kennedy JI
Clin Chest Med; 1990 Mar; 11(1):119-29. PubMed ID: 2182273
[TBL] [Abstract][Full Text] [Related]
11. Interstitial pneumopathy and low-dosage amiodarone.
Pozzi E; Sada E; Luisetti M; De Rose V; Scelsi M
Eur J Respir Dis; 1984 Nov; 65(8):620-2. PubMed ID: 6519218
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients.
Akoun GM; Cadranel JL; Blanchette G; Milleron BJ; Mayaud CM
Chest; 1991 May; 99(5):1177-82. PubMed ID: 1673380
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
Xaubet A; Roca J; Rodriguez-Roisin R; Herranz J; Marin A; Lomeña F; Montserrat JM; Agustí-Vidal A
Respiration; 1987; 52(4):272-80. PubMed ID: 3438590
[TBL] [Abstract][Full Text] [Related]
14. [Steroid-refractory amiodarone-induced pulmonary fibrosis. Clinical features and morphology after an amiodarone-free interval of 3 months].
Esinger W; Schleiffer T; Leinberger H; Hertrich F; Köhler G; Gröger C; Raute-Kreinsen U
Dtsch Med Wochenschr; 1988 Oct; 113(42):1638-41. PubMed ID: 3181014
[TBL] [Abstract][Full Text] [Related]
15. [Pneumonitis induced by amiodarone].
Terra Filho M; Vargas FS; Cukier A; Teixeira LR; Pinto RM; Pileggi F
Arq Bras Cardiol; 1989 Oct; 53(4):201-5. PubMed ID: 2483501
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone pulmonary toxicity. Clinical, cytologic and ultrastructural findings.
Stein B; Zaatari GS; Pine JR
Acta Cytol; 1987; 31(3):357-61. PubMed ID: 3473872
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
Martin WJ; Standing JE
J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
[TBL] [Abstract][Full Text] [Related]
18. [Amiodarone: a new etiology of diffuse interstitial pneumopathy? Apropos of 2 personal cases and 10 cases from the literature].
Vergnon JM; Wiesendanger T; Bellemin JP; Brune J
Rev Mal Respir; 1984; 1(1):43-50. PubMed ID: 6463349
[TBL] [Abstract][Full Text] [Related]
19. [Drug pneumopathy. Early anatomo-pathologic study].
Magar Y; Vaury P; Gacouin JC; Sauvaget J
Therapie; 1984; 39(6):711-2. PubMed ID: 6531744
[No Abstract] [Full Text] [Related]
20. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature.
Coudert B; Bailly F; Lombard JN; Andre F; Camus P
Chest; 1992 Oct; 102(4):1005-12. PubMed ID: 1395734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
